Search

Stocks Boosted On Positive Trial Updates For Possible Covid-19 Treatment



US stocks indices have received a nice boost in the session on Wednesday, as further optimism is sparked regarding the testing of Gilead Sciences' Remdesivir Covid-19 treatment.


The company in a press release Gilead Sciences said preliminary results of a coronavirus drug trial have shown at least 50% of patients that have been treated with a 5-day dosage of antiviral drug Remdesivir, improved and more than half were discharged from the hospital within two weeks.

In terms of the clinical trial, it involves patients with severe cases of Covid-19. The severe study is “single-arm,” meaning it did not evaluate the drug against a control group of patients who didn’t receive the drug.


Gilead added that a government-run clinical trial of evaluating the treatment met the study's primary endpoint. That specific study is being conducted by the National Institute of Allergy and Infectious Diseases, which is expected to provide additional information about that trial soon.


In other news, Japanese Prime Minister Shinzo Abe says Japan is on the verge of initiating a fast-track approval process for Remdesivir, the experimental Gilead Sciences antiviral, to treat patients infected by the novel coronavirus according to local press.


What does this mean for the markets?


It has further promoted this week’s theme which has been risk appetite, boosting the riskier assets; stocks and in FX, AUD, NZD, CAD, specifically remain very strong, with USD underperformance given the current market tone.

WANT TO BECOME AN ALL-ROUND TRADER?!


Fundamentals are not easy to master, which is why we wanted to make them greatly understandable for the everyday person.


Our fundamental course, helps anyone understand them, all curriculum is very much fun, informative and packed with much energy. It will help you transition into an all-round trader, implementing fundamental and technicals to provide the edge when trading.

Click here to get started today!

ALTERNATIVELY...


We cover fundamental and technical analysis every single day for our members. Click here to view our membership packages.

Copyright © 2020 FreakNetwork All Rights Reserved